Davide Castioni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Davide Castioni has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Giorgio Gasparini
Department of Orthopaedic and Trauma Surgery, “Magna Graecia” University, “Renato Dulbecco” University Hospital, 88100 Catanzaro, Italy
18 shared publications - Michele Mercurio
Department of Orthopaedic and Trauma Surgery, “Magna Graecia” University, “Renato Dulbecco” University Hospital, 88100 Catanzaro, Italy
18 shared publications - Olimpio Galasso
Department of Medicine, Surgery and Dentistry, University of Salerno, 84081 Baronissi, Italy
11 shared publications - Filippo Familiari
Department of Orthopaedic and Trauma Surgery, Magna Graecia University, Catanzaro, Italy
6 shared publications Olimpio Galasso
Department of Orthopaedic and Trauma Surgery, "Magna Græcia" University, Mater Domini" University Hospital, Catanzaro, Italy
6 shared publications- Daniele Fanelli
Department of Rehabilitation Medicine, Woodend Hospital, Aberdeen, UK
5 shared publications
Latest Publications
- 1 April 2024
- Published by Edizioni Minerva Medica in Minerva Orthopedics
- Vol. 75 (2) , 88-96
Radiological results and clinical outcomes of the Metaizeau technique for pediatric radial neck fractures. A retrospective study on a reliable surgical option in children
Article: Radiological results and clinical outcomes of the Metaizeau technique for pediatric radial neck fractures. A retrospective study on a reliable surgical option in children - Minerva Orthopedics 2024 April;75(2):88-96 - Minerva Medica - Journals
- 1 April 2024
- Published by Edizioni Minerva Medica in Minerva Orthopedics
- Vol. 75 (2) , 88-96
Radiological results and clinical outcomes of the Metaizeau technique for pediatric radial neck fractures. A retrospective study on a reliable surgical option in children
Article: Radiological results and clinical outcomes of the Metaizeau technique for pediatric radial neck fractures. A retrospective study on a reliable surgical option in children - Minerva Orthopedics 2024 April;75(2):88-96 - Minerva Medica - Journals
- Open Access
- 7 November 2023
- Published by Elsevier in JSES International
- Vol. 8 (1) , 185-190
Clinical outcomes are unchanged after a mean of 12 years after reverse shoulder arthroplasty: a long-term re-evaluation
- 7 November 2023
- Published by Elsevier in JSES International
- Vol. 8 (1) , 185-190
Open AccessClinical outcomes are unchanged after a mean of 12 years after reverse shoulder arthroplasty: a long-term re-evaluation
- 27 September 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 33 (1) , e44-e47
Response to Lievano regarding: “better functional outcomes and a lower infection rate can be expected after superior capsular reconstruction in comparison with latissimus dorsi tendon transfer for massive, irreparable posterosuperior rotator cuff tears: a systematic review”
- 27 September 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 33 (1) , e44-e47
Response to Lievano regarding: “better functional outcomes and a lower infection rate can be expected after superior capsular reconstruction in comparison with latissimus dorsi tendon transfer for massive, irreparable posterosuperior rotator cuff tears: a systematic review”
- Open Access
- 30 March 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 32 (9) , 1953-1959
Postoperative psychological factors and quality of life but not shoulder brace adherence affect clinical outcomes after arthroscopic rotator cuff repair
- 30 March 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 32 (9) , 1953-1959
Open AccessPostoperative psychological factors and quality of life but not shoulder brace adherence affect clinical outcomes after arthroscopic rotator cuff repair
- 14 December 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 32 (4) , 892-906
Better functional outcomes and a lower infection rate can be expected after superior capsular reconstruction in comparison with latissimus dorsi tendon transfer for massive, irreparable posterosuperior rotator cuff tears: a systematic review
- 14 December 2022
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 32 (4) , 892-906
Better functional outcomes and a lower infection rate can be expected after superior capsular reconstruction in comparison with latissimus dorsi tendon transfer for massive, irreparable posterosuperior rotator cuff tears: a systematic review
- 1 July 2022
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 143 (2) , 1117-1131
Revision surgery for periprosthetic elbow infection: eradication rate, complications, and functional outcomes—a systematic review
Introduction The aim of this systematic review was to investigate the outcomes of revision surgery after periprosthetic elbow infection (PEI). Material and methods Eighteen studies with 332 PEI that underwent revision surgery were included. Demographics, laboratory and microbiological data, types of implants, surgical techniques with complications and reoperations, eradication rates, and clinical and functional outcomes were reported. Results Staphylococcus aureus was the most common microorganism (40%). Pre-operatively, the mean white blood cell count was 8400 ± 4000 per microliter; the mean C-reactive protein level was 41.6 ± 66.9 mg/dl, and the mean erythrocyte sedimentation rate was 45 ± 66.9 mm/h. The Coonrad–Morrey total elbow prosthesis represented 41.2% of the infected implant, and it also represented the most common system used for the PEI revision surgery. Two-stage revision and debridement and implant retention (DAIR) were the most common procedures performed for PEI, and, on the whole, they represented 35.7 and 32.7%, respectively. The eradication rate was 76% with 2-stage, 71% with resection arthroplasty (RA), 66.7% with 1-stage, 57.7% with DAIR, and 40% with arthrodesis (EA). DAIR showed a significantly lower eradication rate than 2-stage (P = 0.003). The mean postoperative Mayo Elbow Performance Score was significantly higher in patients who underwent DAIR, and 2-stage compared with RA (P < 0.001 for all). Postoperative flexion–extension ROM was significantly higher in patients who underwent DAIR compared with 1-stage, 2-stage, and RA (P < 0.001 for all). Moreover, 1-stage and 2-stage showed a significantly greater postoperative flexion–extension ROM compared with RA (P < 0.001 for all). Reoperations occurred in 40% of patients after EA, 33.3% after 1-stage, 26.9% after DAIR and RA, and 24.1% after 2-stage. Conversion to amputation occurred in 2.2% of patients after RA and 1% after DAIR. Conclusions Two-stage revision and DAIR are the most common procedures used to manage PEI; however, the former procedure showed a significantly higher eradication rate. Resection arthroplasty showed a high eradication rate, but postoperative lower clinical and functional outcomes limit the indications for this technique. One-stage procedure showed a limited role in the current practice of PEI treatment. Level of evidence Level IV.
- 1 July 2022
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 143 (2) , 1117-1131
Revision surgery for periprosthetic elbow infection: eradication rate, complications, and functional outcomes—a systematic review
Introduction The aim of this systematic review was to investigate the outcomes of revision surgery after periprosthetic elbow infection (PEI). Material and methods Eighteen studies with 332 PEI that underwent revision surgery were included. Demographics, laboratory and microbiological data, types of implants, surgical techniques with complications and reoperations, eradication rates, and clinical and functional outcomes were reported. Results Staphylococcus aureus was the most common microorganism (40%). Pre-operatively, the mean white blood cell count was 8400 ± 4000 per microliter; the mean C-reactive protein level was 41.6 ± 66.9 mg/dl, and the mean erythrocyte sedimentation rate was 45 ± 66.9 mm/h. The Coonrad–Morrey total elbow prosthesis represented 41.2% of the infected implant, and it also represented the most common system used for the PEI revision surgery. Two-stage revision and debridement and implant retention (DAIR) were the most common procedures performed for PEI, and, on the whole, they represented 35.7 and 32.7%, respectively. The eradication rate was 76% with 2-stage, 71% with resection arthroplasty (RA), 66.7% with 1-stage, 57.7% with DAIR, and 40% with arthrodesis (EA). DAIR showed a significantly lower eradication rate than 2-stage (P = 0.003). The mean postoperative Mayo Elbow Performance Score was significantly higher in patients who underwent DAIR, and 2-stage compared with RA (P < 0.001 for all). Postoperative flexion–extension ROM was significantly higher in patients who underwent DAIR compared with 1-stage, 2-stage, and RA (P < 0.001 for all). Moreover, 1-stage and 2-stage showed a significantly greater postoperative flexion–extension ROM compared with RA (P < 0.001 for all). Reoperations occurred in 40% of patients after EA, 33.3% after 1-stage, 26.9% after DAIR and RA, and 24.1% after 2-stage. Conversion to amputation occurred in 2.2% of patients after RA and 1% after DAIR. Conclusions Two-stage revision and DAIR are the most common procedures used to manage PEI; however, the former procedure showed a significantly higher eradication rate. Resection arthroplasty showed a high eradication rate, but postoperative lower clinical and functional outcomes limit the indications for this technique. One-stage procedure showed a limited role in the current practice of PEI treatment. Level of evidence Level IV.
- 1 July 2022
- Published by Elsevier in Foot and Ankle Surgery
- Vol. 28 (5) , 550-556
Periprosthetic ankle infection: eradication rate, complications, and limb salvage. A systematic review
- 1 July 2022
- Published by Elsevier in Foot and Ankle Surgery
- Vol. 28 (5) , 550-556
Periprosthetic ankle infection: eradication rate, complications, and limb salvage. A systematic review
- 29 June 2022
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 14 (3) , 36589
Trend of Perioperative CRP (C-Reactive Protein) Levels in Non-Infected Total Knee Arthroplasty
The aim of this prospective study was to define the perioperative trend of C-reactive protein (CRP) in non-infected total knee arthroplasty (TKA). CRP was evaluated in 42 patients the day before surgery and 4 and 30 days after surgery. Functional and radiological evaluation was scheduled for 3, 6, and 12 months after surgery. Preoperatively, the median CRP was 3.2 mg/L (IQR,3.2-4.2) (reference range, 0-5 mg/L); 4 and 30 days after surgery, it measured 57.6 mg/L (IQR,36.1-96.4) and 5.3 mg/L (IQR,3.0-11.8), respectively. There were significant differences between the CRP preoperatively and 4 days after surgery (p<0.001) and between CPR levels 4 and 30 days after surgery (p<0.001) but not between CRP values preoperatively and 30 days after surgery (p=0.181). Higher preoperative CRP was associated to heart disease and chronic renal failure (r=0.329, p=0.036, and r=0.437, p=0.004, respectively). Four days after surgery, higher CRP was associated to older patients (r=0.311, p=0.048). In summary, 30 days after primary non-infected TKA, CRP levels were comparable to preoperative values. Older age and comorbidities should be carefully evaluated using postoperative CRP as diagnostic marker for the early detection of infection.
- 29 June 2022
- Published by Open Medical Publishing in Orthopedic Reviews
- Vol. 14 (3) , 36589
Trend of Perioperative CRP (C-Reactive Protein) Levels in Non-Infected Total Knee Arthroplasty
The aim of this prospective study was to define the perioperative trend of C-reactive protein (CRP) in non-infected total knee arthroplasty (TKA). CRP was evaluated in 42 patients the day before surgery and 4 and 30 days after surgery. Functional and radiological evaluation was scheduled for 3, 6, and 12 months after surgery. Preoperatively, the median CRP was 3.2 mg/L (IQR,3.2-4.2) (reference range, 0-5 mg/L); 4 and 30 days after surgery, it measured 57.6 mg/L (IQR,36.1-96.4) and 5.3 mg/L (IQR,3.0-11.8), respectively. There were significant differences between the CRP preoperatively and 4 days after surgery (p<0.001) and between CPR levels 4 and 30 days after surgery (p<0.001) but not between CRP values preoperatively and 30 days after surgery (p=0.181). Higher preoperative CRP was associated to heart disease and chronic renal failure (r=0.329, p=0.036, and r=0.437, p=0.004, respectively). Four days after surgery, higher CRP was associated to older patients (r=0.311, p=0.048). In summary, 30 days after primary non-infected TKA, CRP levels were comparable to preoperative values. Older age and comorbidities should be carefully evaluated using postoperative CRP as diagnostic marker for the early detection of infection.
- 19 April 2022
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 37 (9) , 1879-1887.e4
Cemented Total Knee Arthroplasty Shows Less Blood Loss but a Higher Rate of Aseptic Loosening Compared With Cementless Fixation: An Updated Meta-Analysis of Comparative Studies
- 19 April 2022
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 37 (9) , 1879-1887.e4
Cemented Total Knee Arthroplasty Shows Less Blood Loss but a Higher Rate of Aseptic Loosening Compared With Cementless Fixation: An Updated Meta-Analysis of Comparative Studies
- 16 March 2022
- Published by Springer Nature in International Orthopaedics
- Vol. 46 (6) , 1233-1240
The use of a surgical helmet system with a high-efficiency particulate air filter as possible protection equipment during the coronavirus disease 2019 pandemic: a double-blinded randomized control study
Purpose The rapid spread of coronavirus disease 2019 (COVID-19) has increased the use of personal protective equipment. The purpose of this study was to investigate whether a commercially available sterile surgical helmet system (SSHS) can be considered protective against COVID-19 and therefore safe for use. Methods A double-blinded randomized controlled study was performed to investigate the efficacy of the ViVi® SSHS with a high-efficiency particulate air filter called HFD Hood (THI, Total Healthcare Innovation GmbH, Feistritz im Rosental, Austria) to protect against respiratory droplets. Forty recruited participants were divided into two different groups. The SSHS was tested using a validated qualitative test for respirator masks through saccharin or placebo solutions based on random allocation into two cohorts. Saccharin droplets are a validated surrogated marker for any elements of viral size, such as coronaviruses. A positive report of sweet taste after saccharin exposure was suggestive of ViVi® SSHS inefficacy in protection against droplets. Results One participant out of 21 (4.8%) reported positive for taste within the placebo cohort, while five out of 19 (26.3%) reported positive for taste within the saccharin cohort upon testing. Two out of 21 (9.5%) participants reported positive for taste within the placebo cohort, and two out of 19 (10.5%) reported positive for taste within the saccharin cohort upon retesting. There were no statistically significant differences between the saccharin and placebo groups in either the test or retest measurements (p = 0.085 and p = 1.000, respectively). Conclusions This study demonstrates that the ViVi® SSHS equipped with HFD Hood protects against respiratory droplets, increasing protection against several microorganisms, including the virus that causes COVID-19, allowing surgeons to carry out procedures on COVID-positive patients in a more comfortable and safer way.
- 16 March 2022
- Published by Springer Nature in International Orthopaedics
- Vol. 46 (6) , 1233-1240
The use of a surgical helmet system with a high-efficiency particulate air filter as possible protection equipment during the coronavirus disease 2019 pandemic: a double-blinded randomized control study
Purpose The rapid spread of coronavirus disease 2019 (COVID-19) has increased the use of personal protective equipment. The purpose of this study was to investigate whether a commercially available sterile surgical helmet system (SSHS) can be considered protective against COVID-19 and therefore safe for use. Methods A double-blinded randomized controlled study was performed to investigate the efficacy of the ViVi® SSHS with a high-efficiency particulate air filter called HFD Hood (THI, Total Healthcare Innovation GmbH, Feistritz im Rosental, Austria) to protect against respiratory droplets. Forty recruited participants were divided into two different groups. The SSHS was tested using a validated qualitative test for respirator masks through saccharin or placebo solutions based on random allocation into two cohorts. Saccharin droplets are a validated surrogated marker for any elements of viral size, such as coronaviruses. A positive report of sweet taste after saccharin exposure was suggestive of ViVi® SSHS inefficacy in protection against droplets. Results One participant out of 21 (4.8%) reported positive for taste within the placebo cohort, while five out of 19 (26.3%) reported positive for taste within the saccharin cohort upon testing. Two out of 21 (9.5%) participants reported positive for taste within the placebo cohort, and two out of 19 (10.5%) reported positive for taste within the saccharin cohort upon retesting. There were no statistically significant differences between the saccharin and placebo groups in either the test or retest measurements (p = 0.085 and p = 1.000, respectively). Conclusions This study demonstrates that the ViVi® SSHS equipped with HFD Hood protects against respiratory droplets, increasing protection against several microorganisms, including the virus that causes COVID-19, allowing surgeons to carry out procedures on COVID-positive patients in a more comfortable and safer way.